Erika L Crowley Selected Research

Acrodermatitis (Gianotti Crosti Syndrome)

7/2019	The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
1/2019	Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erika L Crowley Research Topics

Disease

2	Atopic Dermatitis (Atopic Eczema) 10/2020 - 09/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 07/2019
2	Acrodermatitis (Gianotti Crosti Syndrome) 07/2019 - 01/2019
1	Pruritus (Itching) 09/2020
1	Ulcerative Colitis 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Psoriatic Arthritis 01/2020
1	Alopecia Areata 05/2019
1	Synovitis 01/2018
1	Acne Vulgaris 01/2018
1	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2018
1	Hyperostosis 01/2018
1	Hidradenitis Suppurativa 01/2018
1	Back Pain (Backache) 01/2018
1	Dermatitis 01/2018
1	Osteitis 01/2018

Drug/Important Bio-Agent (IBA)

2	abrocitinibIBA 10/2020 - 09/2020
2	Alitretinoin FDA Link 01/2019 - 01/2018
2	Adalimumab (Humira)FDA Link 01/2019 - 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	ixekizumabIBA 01/2020
1	secukinumabIBA 01/2020
1	brodalumabIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Janus Kinase InhibitorsIBA 05/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018

Therapy/Procedure

4	Therapeutics 09/2020 - 01/2018
2	Biological Therapy 07/2019 - 01/2019
1	Transjugular Intrahepatic Portasystemic Shunt 07/2019
1	Injections 01/2018